Recursion Pharmaceuticals
RXRX
RXRX
264 hedge funds and large institutions have $1.72B invested in Recursion Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 110 increasing their positions, 52 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
264
Holders Change
-4
Holders Change %
-1.49%
% of All Funds
3.82%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
44
Increased
110
Reduced
52
Closed
46
Calls
$11.4M
Puts
$19.8M
Net Calls
-$8.4M
Net Calls Change
+$1.56M
Top Buyers
| 1 |
AIM
1
ARK Investment Management
St. Petersburg,
Florida
|
$216M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$84.8M |
| 3 |
3
BlackRock
New York
|
$137M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$160M |
| 5 |
DM
5
Deerfield Management
New York
|
$15.3M |
